Lynn D. Wilson, MD, MPH, FASTRO
Dr. Lynn D. Wilson is a board-certified radiation oncologist at the Yale School of Medicine and Smilow Cancer Hospital at Yale New Haven. Dr. Wilson leverages modern radiation therapy technology and specialized techniques to provide palliative care and therapeutic outcomes for patients struggling with challenging malignancies.[1]
Education and Career
Dr. Wilson graduated from Denison University and earned a master of Public Health in Health Services Administration degree from Yale University School of Medicine before earning his medical degree at George Washington University School of Medicine.
He completed his internship and residency in Radiology at Yale-New Haven Hospital in New Haven, Connecticut, serving as Chief Resident before joining the faculty at Yale School of Medicine in 1994.
Dr. Wilson has served several roles at Yale Health and is currently Deputy Chief Medical Officer for Radiation Oncology at Smilow Cancer Hospital.
Other responsibilities include:[1]
- Professor of Therapeutic Radiology and Dermatology
- Associate Director of the Residency Training Program for Therapeutic Radiology
- Executive Vice Chairman of the Department of Therapeutic Radiology
- Director of Clinical Affairs for the Department of Therapeutic Radiology
Dr. Wilson was the inaugural recipient of the David J. Leffell, MD Prize for Clinical Excellence and is a past recipient of the Francis Gilman Blake Award for teaching at Yale School of Medicine. In 2011, he was named a Fellow of the American Society for Radiation Oncology.[1]
He strongly believes that successful treatment of patients diagnosed with lung cancer, mesothelioma, breast cancer, and other malignancies and diseases can be “best achieved through multidisciplinary collaboration among specialists focused on the patient.”
Research
Dr. Wilson’s research explores outcomes and treatment-related factors for patients receiving care for lung cancers, breast cancers, and cutaneous lymphoma.
He has a particular interest in the use of radiation to treat lung neoplasms, mycosis fungoides, and lymphoma. He also has research interests surrounding T-cells and radiation oncology.
His recent publications include:[1]
. 245 Factors associated with in-hospital mortality in mycosis fungoides patients. King A, Lee V, Mirza F, Jairam V, Yu J, Park H, Girardi M, Wilson L, An Y. 245 Factors associated with in-hospital mortality in mycosis fungoides patients. Journal Of Investigative Dermatology 2021, 141: s44. DOI: 10.1016/j.jid.2021.02.267.
. CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated. Peters G, Gao S, Knowlton C, Zhang A, Evans S, Higgins S, Wilson L, Saltmarsh N, Picone M, Moran M. CLO21-025: Benefit of Deep Inspiratory Breath Hold for Right Breast Cancer When Regional Lymph Nodes Are Irradiated. Journal Of The National Comprehensive Cancer Network 2021, 19: clo21-025. DOI: 10.6004/jnccn.2020.7707.
· Predictive Value of PET-CT in Patients with T-Cell Lymphoma Undergoing Autologous and Allogeneic Stem Cell Transplant. Isufi I, Chandhok N, Boddu P, Pucar D, Seropian S, Gowda L, Perreault S, Wilson L, Roberts K, Foss F. Predictive Value of PET-CT in Patients with T-Cell Lymphoma Undergoing Autologous and Allogeneic Stem Cell Transplant. Transplantation And Cellular Therapy 2020, 26: s244. DOI: 10.1016/j.bbmt.2019.12.492.
· A Blinded, Prospective Study of Problematic Plan Detection During Physician Chart Rounds. Talcott W, Lincoln H, Kelly J, Tressel L, Wilson L, Decker R, Evans S. A Blinded, Prospective Study of Problematic Plan Detection During Physician Chart Rounds. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s23-s24. DOI: 10.1016/j.ijrobp.2019.06.425.
· PV-0045 Is proton therapy a “pro” for breast cancer? A comparison of proton vs. non-proton RT using the NCDB. Chowdhary M, Lee A, Gao S, Barry P, Diaz R, Bagadiya N, Park H, Yu J, Wilson L, Moran M, Higgins S, Knowlton C, Patel K. PV-0045 Is proton therapy a “pro” for breast cancer? A comparison of proton vs. non-proton RT using the NCDB. Radiotherapy And Oncology 2019, 133: s15. DOI: 10.1016/s0167-8140(19)30465-7.
